Treatment and treatment results for unselected metastatic colorectal cancer patients according to BRAF/KRAS gene analyses (446 cases with BRAF analyses, 442 cases with both BRAF and KRAS analyses).

Figshare2015-12-03 更新2026-04-29 收录

下载链接：

https://figshare.com/articles/dataset/_Treatment_and_treatment_results_for_unselected_metastatic_colorectal_cancer_patients_according_to_BRAF_KRAS_gene_analyses_446_cases_with_BRAF_analyses_442_cases_with_both_BRAF_and_KRAS_analyses_/1468133

下载链接

链接失效反馈

官方服务：

资源简介：

Abbreviations: CR; complete response, PR; partial response, PD; progressive disease, PFS; progression-free survival, PS; performance status, BSC; best supportive care, ns; not significant, m; months. Evaluable patients with KRAS/BRAF analyses were n = 275 for responses/PFS on 1st-line chemotherapy (51 mutBRAF, 112 mutKRAS, 112 wtKRAS/BRAF), n = 157 for responses/PFS on 2nd-line chemotherapy (26 mutBRAF, 65 mutKRAS, 65 wtKRAS/BRAF) and n = 60 for responses/PFS on 3rd-line chemotherapy (4 mutBRAF).Treatment and treatment results for unselected metastatic colorectal cancer patients according to BRAF/KRAS gene analyses (446 cases with BRAF analyses, 442 cases with both BRAF and KRAS analyses).

创建时间：

2015-12-03